Notices. DEPARTMENT OF JUSTICE
535 words·~2 min read·
/register/2001/12/20/01-31280·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4410-09-M DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on August 17, 2001, Cerilliant Corporation, 14050 Summit Drive #121, P.O. Box 201088, Austin, Texas 78708-0189, made application by renewal to the Drug Enforcement Administration
(DEA)for registration as bulk manufacturer of the basic classes of controlled substances listed below: Drug Schedule Cathinone
(1235)I Methcathinone
(1237)I N-Ethylamphetamine
(1475)I N, N-Dimethylamphetamine
(1480)I Aminorex
(1585)I 4-Methylaminorex (cis isomer)
(1590)I Gamma hydroxybutyric acid
(2010)I Methaqualone
(2565)I Alpha-Ethyltryptamine
(7249)I Lysergic acid diethylamide
(7315)I Tetrahydrocannabinols
(7370)I Mescaline
(7381)I 3, 4, 5-Trimethoxyamphetamine
(7390)I 4-Bromo-2, 5-dimethoxyaphetamine
(7391)I 4-Bromo-2, 5-dimethoxphenethylamine
(7392)I 4-Methyl-2, 5-dimethoxyamphetamine
(7395)I 2, 5-Dimethoxyamphetamine
(7396)I 2, 5-Dimethoxy-4-ethylamphetamie
(7399)I 3, 4-Methylenedioxyamphetamine
(7400)I 5-Methoxy-3, 4-methylenedioxyamphetamine
(7401)I N-Hydroxy-3, 4-methylenedioxyamphetamine
(7402)I 3, 4-Methylenedioxy-N-ethylamphetamine
(7404)I 3, 4-Methylenedioxymethamphetamine
(7405)I 4-Methoxyamphetamine
(7411)I Bufotenine
(7433)I Diethyltryptamine
(7434)I Dimethyltryptamine
(7435)I Psilocybin
(7437)I Psilocyn
(7438)I Acetyldihydrocodeine
(9051)I Benzylmorphine
(9052)I Codeine-N-oxide
(9053)I Dihydromorphine
(9145)I Heroin
(9200)I Hydromorphinol
(9301)I Methyldihydromorphine
(9304)I Morphone-N-oxide
(9307)I Normorphine
(9313)I Pholcodine
(9314)I Acetylmethadol
(9601)I Allyprodine
(9602)I Alphacetylmethadol except Levo-Alphacetylmethadol
(9603)I Alphameprodine
(9604)I Alphamethadol
(9605)I Betacetylmethadol
(9607)I Betameprodine
(9608)I Betamethadol
(9609)I Betaprodine
(9611)I Hydromorphinol
(9627)I Noracymethadol
(9633)I Norlevorphanol
(9634)I Normethadone
(9635)I Trimeperidine
(9646)I Phenomorphan
(9647)I Para-Fluorofentanyl
(9812)I 3-Methylfentanyl
(9813)I Alpha-methylfentanyl
(9814)I Acetyl-alpha-methylfentanyl
(9815)I Beta-hydroxyfentanyl
(9830)I Beta-hydroxy-3-methylfentanyl
(9831)I Alpha-Methylthiofentianyl
(9832)I 3-Methylthiofentanyl
(9833)I Thiofentanyl
(9835)I Amphetamine
(1100)II Methamphetamine
(1105)II Phenmetrazine
(1631)II Methylphenidate
(1724)II Amobarbital
(2125)II Pentobarbital
(2270)II Secobarbital
(2315)II Glutethimide
(2550)II Nabilone
(7379)II 1-Phenylcyclohexylamine
(7460)II Phencyclidine
(7471)II 1-Piperidinocyclohexanecarbonitrile
(8603)II Alphaprodine
(9010)II Cocaine
(9041)II Codeine
(9050)II Dihydrocodeine
(9220)II Oxycodone
(9143)II Hydromorphone
(9150)II DIphenoxylate
(9170)II Benzoylecgonine
(9180)II Ethylmorphine
(9190)II Hydrocodone
(9193)II Levomethorphan
(9210)II Levorphanol
(9200)II Isomethadone
(9226)II Meperidine
(9230)II Methadone
(9250)II Methadone-intermediate
(9254)II Dextropropoxyphene, bulk (non-dosage forms)
(9273)II Morphine
(9300)II Thebaine
(9333)II Levo-alphacetylmethadol
(9648)II Oxymorphone
(9652)II Noroxymorphone
(9668)II Racemethorphane
(9732)II Alfentanil
(9737)II Sufentanil
(9740)II Fentanyl
(9801)II The firm plans to manufacture small quantities of the listed controlled substances to make deuterated and non-deuterated drug reference standards which will be distributed to analytical and forensic laboratories for drug testing programs. Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistance Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than February 19, 2002. Dated: November 16, 2001. Laura M. Nagel, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 01-31280 Filed 12-19-01; 8:45 am]